Disposition of Formononetin via Enteric Recycling: Metabolism and Excretion in Mouse Intestinal Perfusion and Caco-2 Cell Models
Authors:
- 27 May 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 2 (4) , 319-328
Abstract
The purpose of this study was to determine the absorption and metabolism of formononetin using the mouse intestinal perfusion model, mouse intestinal homogenate, and the Caco-2 cell culture model. In the perfusion model where upper and lower small intestine were perfused simultaneously, absorption of formononetin was rapid and dimensionless effective permeabilities of formononetin (2.53−2.90) were similar to those for rats. Moreover, the amounts of sulfates excreted in mouse intestine (8−11 nmol/30 min/10 cm) were significantly higher than those for rats whereas the amounts of glucuronides excreted (7−10 nmol/30 min/10 cm) were comparable. Small amounts of formononetin glucuronide but not sulfate were found in mouse bile, but the total amounts were 120 times less than those for rats. Multidrug-resistance-related protein (MRP) inhibitors (leukotriene C4 plus MK-571, C26H26ClN2O3S2) significantly decreased the excretion of glucuronide and sulfate in mouse intestine (52−74% for glucuronide, 13−26% for sulfate) and in Caco-2 cells (92% for glucuronide, 37% for sulfate). They also inhibited formation of conjugates in intestinal homogenate (∼60% for glucuronide, ∼30% for sulfate) and Caco-2 cell lysate (∼92% for glucuronide, ∼37% for sulfate). Organic anion transporter (OAT) inhibitors (estrone sulfate plus dihydroepiandrosterone sulfate) did not significantly change the excretion of formononetin conjugates in either model, even though they significantly decreased the formation of both. In conclusion, our study showed that formononetin has similar absorption in rat and mouse intestine, but metabolism was species-dependent. The mouse perfusion model may have an advantage over the rat intestinal perfusion model for flavonoid disposition studies in that both sulfates and glucuronides are excreted, as shown in humans. Keywords: Conjugates; coupling; excretion; mouse intestine; perfusion; formononetinKeywords
This publication has 16 references indexed in Scilit:
- Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal LumenMolecular Pharmacology, 2005
- Disposition Mechanisms of Raloxifene in the Human Intestinal Caco-2 ModelThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatography-tandem mass spectrometry with []isoflavone internal standardsAnalytical Biochemistry, 2002
- Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverageThe American Journal of Clinical Nutrition, 2002
- Resolution of P‐glycoprotein and non‐P‐glycoprotein effects on drug permeability using intestinal tissues from mdr1a (−/−) miceBritish Journal of Pharmacology, 2002
- Utility of Rat Liver Slices to Estimate Hepatic Clearance for Application in Physiologically Based Pharmacokinetic Modeling: A Study with Tolbutamide, a Compound with Low Extraction EfficiencyDrug Metabolism and Disposition, 2002
- Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy menThe American Journal of Clinical Nutrition, 2002
- Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone SupplementsThe Journal of Nutrition, 2001
- DIETARY PHYTOESTROGENSAnnual Review of Nutrition, 1997
- The Variable Metabolic Response to Dietary Isoflavones in HumansExperimental Biology and Medicine, 1995